Browsing: Vaccine

A new review argues that the global HIV response is preparing too narrowly for scientific discovery and not enough for what must happen after an effective vaccine is developed. Although oral and long-acting pre-exposure prophylaxis, or PrEP, can prevent HIV acquisition, access gaps, stigma, clinic dependence and adherence barriers continue to limit their population-level impact,…

The race to contain the Bundibugyo Ebola outbreak has entered a critical phase, with Oxford University launching the first human trial of a vaccine targeting the strain, while researchers in the Democratic Republic of Congo have begun testing Gilead Sciences’ experimental antiviral, as a post-exposure treatment. The developments come as the outbreak spreads to additional…

In a bold move, U.S. health secretary Robert F. Kennedy Jr. has disrupted traditional vaccine policies, proposing unprecedented changes that have stirred controversy within the public health sector. Since taking office, Kennedy has sought to scale back the federal immunization schedule for American children, igniting debates among vaccine experts and legal challenges from professional medical…

Helminth parasites of the Schistosoma genus cause roughly 290,000 deaths annually, primarily in tropical and subtropical regions. In addition, an estimated 250 million people are currently chronically infected with Schistosoma parasites—with an additional 800 million people at risk of getting the infection—making schistosomiasis second only to malaria among the world’s deadliest tropical parasitic diseases